Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | N/A | -4.55% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.29 | N/A | -4.55% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism about future prospects. They emphasized their commitment to innovation and growth.
Management highlighted ongoing investments in innovation.
They expressed confidence in long-term growth despite current challenges.
Boston Scientific's earnings report showed a slight miss on EPS, which may raise some concerns among investors. However, the stock reacted positively, gaining 0.81%, likely due to management's focus on innovation and long-term growth strategies. The lack of revenue data and guidance leaves some uncertainty for future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CANADIAN NATL RY CO
Apr 24, 2017